180 related articles for article (PubMed ID: 9673345)
1. Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors.
Sinha AA; Quast BJ; Wilson MJ; Reddy PK; Fernandes ET; Ewing SL; Gleason DF
Anticancer Res; 1998; 18(3A):1385-92. PubMed ID: 9673345
[TBL] [Abstract][Full Text] [Related]
2. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
3. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
Sinha AA; Quast BJ; Reddy PK; Elson MK; Wilson MJ
Anticancer Res; 1999; 19(2A):893-902. PubMed ID: 10368631
[TBL] [Abstract][Full Text] [Related]
4. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
5. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
Lin MF; Lee MS; Zhou XW; Andressen JC; Meng TC; Johansson SL; West WW; Taylor RJ; Anderson JR; Lin FF
J Urol; 2001 Nov; 166(5):1943-50. PubMed ID: 11586265
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of nonmalignant and malignant human prostate in organ culture.
Varani J; Dame MK; Wojno K; Schuger L; Johnson KJ
Lab Invest; 1999 Jun; 79(6):723-31. PubMed ID: 10378515
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
Lopes AD; Davis WL; Rosenstraus MJ; Uveges AJ; Gilman SC
Cancer Res; 1990 Oct; 50(19):6423-9. PubMed ID: 1698122
[TBL] [Abstract][Full Text] [Related]
9. Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy.
Sinha AA; Quast BJ; Wilson MJ; Reddy PK; Gleason DF; Sloane BF
Anat Rec; 1998 Oct; 252(2):281-9. PubMed ID: 9776083
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
Lin MF; Meng TC
Biochem Biophys Res Commun; 1996 Sep; 226(1):206-13. PubMed ID: 8806615
[TBL] [Abstract][Full Text] [Related]
11. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion.
Scott LJ; Clarke NW; George NJ; Shanks JH; Testa NG; Lang SH
Br J Cancer; 2001 May; 84(10):1417-23. PubMed ID: 11355957
[TBL] [Abstract][Full Text] [Related]
12. Histocultures of human prostate tissues for pharmacologic evaluation.
Wientjes MG; Pretlow TG; Badalament RA; Burgers JK; Au JL
J Urol; 1995 Apr; 153(4):1299-302. PubMed ID: 7532726
[TBL] [Abstract][Full Text] [Related]
13. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
[TBL] [Abstract][Full Text] [Related]
14. Immunofluorescent localization of an androgen-dependent isoenzyme of prostatic acid phosphatase in rat ventral prostate.
Terracio L; Rule A; Salvato J; Douglas WH
Anat Rec; 1985 Oct; 213(2):131-9. PubMed ID: 3907418
[TBL] [Abstract][Full Text] [Related]
15. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter.
Zelivianski S; Igawa T; Lim S; Taylor R; Lin MF
Oncogene; 2002 May; 21(23):3696-705. PubMed ID: 12032838
[TBL] [Abstract][Full Text] [Related]
17. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
18. [Culturing of normal and tumor cells of the human prostate].
Cussenot O; Teillac P; Le Duc A; Ketels F; Calvo F
Ann Urol (Paris); 1989; 23(6):533-7. PubMed ID: 2482701
[TBL] [Abstract][Full Text] [Related]
19. Identification of cultured, human, malignant, prostatic epithelial cells.
Stonington OG; Szwec N; Webber M
Natl Cancer Inst Monogr; 1978 Dec; (49):31-3. PubMed ID: 372822
[TBL] [Abstract][Full Text] [Related]
20. The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells.
Lin MF; Garcia-Arenas R; Xia XZ; Biela B; Lin FF
Differentiation; 1994 Aug; 57(2):143-9. PubMed ID: 8070625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
